What Causes Chronic Fatigue Syndrome (ME/CFS)? The Current Science

Chronic fatigue syndrome — more accurately called ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) — is not the same as being very tired. It is a serious, often disabling condition characterised by fatigue that doesn't improve with rest, worsens after activity, and is accompanied by cognitive impairment, unrefreshing sleep, and often pain.

The NHS defines ME/CFS as a long-term condition whose most common symptom is extreme tiredness that does not improve with rest or sleep.

The exact cause remains incompletely understood, but the picture that has emerged — particularly accelerated by long COVID research — points consistently to three overlapping mechanisms: immune system dysfunction, autonomic nervous system disruption, and mitochondrial/cellular energy failure. Understanding these mechanisms matters both for diagnosis and for understanding why certain management approaches help and others actively harm.

Who Gets ME/CFS and How Common Is It

ME/CFS affects an estimated 250,000 people in the UK. It affects women more than men (roughly 3:1 ratio), with peak onset in the 20s–40s and a second peak in adolescence. It can affect children and older adults too.

The most well-established trigger is viral infection. Post-viral ME/CFS has been documented following:

• Epstein-Barr virus (EBV) — the glandular fever virus; one of the best-characterised triggers
• Enteroviruses — gut viruses including coxsackievirus
• COVID-19 — long COVID has dramatically increased recognition of post-viral ME/CFS mechanisms
• Q fever (Coxiella burnetii)
• Other respiratory viruses including influenza

Not everyone who develops ME/CFS has an identified viral trigger — some onset is gradual without a clear precipitating illness. Psychological stress, trauma, surgery, and physical injury have all been associated with onset in some cases. The common thread appears to be a triggering event that disrupts the systems governing immune regulation, autonomic function, and energy metabolism in susceptible individuals.

The Three Core Mechanisms

1. Immune Dysfunction

The most consistently replicated finding in ME/CFS research is evidence of immune dysregulation — an immune system that has failed to return to its normal resting state after a triggering infection.

Persistent cytokine activation: Multiple studies have found elevated levels of pro-inflammatory cytokines in ME/CFS patients, including interferon-gamma, IL-6, IL-1β, and TNF-α. These are the same cytokines that produce "sickness behaviour" during acute infection — the fatigue, cognitive slowing, and withdrawal that force rest. In ME/CFS, this state appears to persist chronically.

Natural killer (NK) cell dysfunction: NK cells — a type of immune cell that provides rapid response to infected cells — show consistently reduced function in ME/CFS. They appear activated but impaired, like an alarm system that's triggered but can't complete its response.

B cell and T cell abnormalities: Several studies have found autoantibodies (antibodies against the body's own tissues) in ME/CFS patients, including antibodies against beta-adrenergic receptors (which regulate heart rate and blood pressure) and muscarinic receptors. This autoimmune component may explain some of the autonomic dysfunction seen in the condition.

Reactivation of latent viruses: EBV, HHV-6, and other herpesviruses remain latent in the body after primary infection and can reactivate. Evidence of viral reactivation in ME/CFS patients suggests the immune system may be perpetually engaged in suppressing latent viral reactivation, contributing to the chronic activation state.

2. Autonomic Nervous System Disruption

The autonomic nervous system (ANS) regulates unconscious bodily functions: heart rate, blood pressure, vascular tone, digestion, temperature regulation. ME/CFS consistently shows disrupted autonomic function, particularly in orthostatic control — the ability to regulate blood pressure and heart rate when standing.

POTS (Postural Orthostatic Tachycardia Syndrome): A substantial proportion of ME/CFS patients have POTS — heart rate increasing excessively when standing (30+ beats per minute), with blood pooling in the lower body. The resulting cerebral hypoperfusion (reduced blood flow to the brain) directly causes fatigue, brain fog, and cognitive impairment. POTS in ME/CFS was underrecognised before long COVID dramatically increased its visibility.

Reduced heart rate variability: Heart rate variability (HRV) — the natural variation in time between heartbeats — is a marker of autonomic flexibility. ME/CFS patients consistently show reduced HRV, indicating a nervous system stuck in a low-flexibility state with impaired capacity to respond to demands.

Neurally mediated hypotension: Some patients experience blood pressure drops on standing (rather than heart rate spikes), producing dizziness, pre-syncope, and severe fatigue. This is driven by the same autonomic dysregulation as POTS but in a different direction.

These autonomic abnormalities explain why activity worsens symptoms: standing up, walking, and exertion all challenge the orthostatic regulation system that is already impaired.

3. Mitochondrial and Cellular Energy Failure

Perhaps the most significant recent advance in ME/CFS understanding is the evidence for impaired cellular energy metabolism.

Reduced oxidative phosphorylation: Studies measuring mitochondrial function in immune cells from ME/CFS patients have found significantly reduced ATP production through oxidative phosphorylation — the primary energy-generating pathway. Cells appear to be forced into less efficient anaerobic energy production, which produces less ATP and more lactate.

The post-exertional energy crash: After physical or cognitive exertion, healthy individuals replenish energy stores during recovery. In ME/CFS, this replenishment is impaired — and crucially, the exertion itself appears to trigger further mitochondrial damage or dysfunction, producing the characteristic PEM (post-exertional malaise) crash 12–48 hours later.

Ion channel abnormalities: Research led by groups including Robert Naviaux has identified abnormalities in cell membrane ion channels in ME/CFS, suggesting the cells are in a chronic defensive metabolic state — similar to the "cell danger response" seen during acute infection — that they cannot exit.

Post-Exertional Malaise: The Defining Feature

PEM is the hallmark of ME/CFS and the feature that most distinguishes it from other fatigue conditions. It refers to the worsening of all symptoms — fatigue, brain fog, pain, sleep disruption, sensory sensitivity — after physical or cognitive exertion.

Critical characteristics:

• Delayed onset: PEM typically begins 12–48 hours after the triggering activity, not immediately. This delay means people often don't connect the crash to its cause.
• Disproportionate severity: The activity that triggers PEM is often trivial — a phone call, a short walk, a social visit. The response is out of proportion to the effort expended.
• Prolonged recovery: Returning to baseline after PEM can take days, weeks, or in severe cases months.
• Cumulative effect: Repeated PEM cycles appear to worsen the underlying condition progressively.

Why this matters for management: The existence of PEM means that standard "push through and exercise" advice — which is appropriate for many fatigue conditions — is actively harmful in ME/CFS. The 2021 NICE guidelines explicitly removed Graded Exercise Therapy (GET) from recommended treatments for ME/CFS after evidence that it worsens outcomes in patients with PEM.

NICE 2021 Guidelines: What Changed

The 2021 NICE guideline update was significant. Previously, GET (progressively increasing exercise) and CBT (to address "unhelpful illness beliefs") were recommended as primary treatments. Both were removed or substantially qualified.

What NICE now recommends:

• Pacing and energy management (including heart rate monitoring to stay below anaerobic threshold)
• Symptomatic treatment for sleep, pain, and mood
• Personalised care planning that acknowledges the fluctuating nature of the condition
• Referral to specialist ME/CFS services where available

What is no longer recommended:

• Graded exercise therapy as a treatment
• CBT as a primary treatment aimed at "correcting unhelpful beliefs" (CBT for managing the psychological burden of a chronic illness remains appropriate)
• Any management approach based on the premise that ME/CFS is primarily a psychological condition maintained by deconditioning or illness beliefs

This change reflected both new evidence and longstanding patient experience that GET caused deterioration in a significant proportion of patients.

Diagnostic Criteria

ME/CFS is diagnosed on clinical criteria — there is no diagnostic blood test. The NICE 2021 criteria require:

1. Substantial functional impairment — significant reduction in ability to perform activities compared to pre-illness baseline, present for 3 or more months
2. Post-exertional malaise — worsening of symptoms after physical or cognitive activity, with delayed onset and disproportionate severity
3. Unrefreshing sleep — waking unrestored regardless of sleep duration
4. Plus at least one of:
   • Cognitive impairment — brain fog, difficulty concentrating, impaired working memory
   • Orthostatic intolerance — worsening on standing, dizziness, POTS symptoms

Other conditions that could explain the symptoms must be excluded (thyroid dysfunction, anaemia, sleep apnoea, depression, autoimmune conditions), but ME/CFS can coexist with other conditions.

Management: What Actually Helps

Energy management and pacing: The evidence-supported approach. Identifying your energy envelope — the activity level you can sustain without triggering PEM — and staying consistently within it. Not doing more on good days (the "boom-bust" cycle is a key driver of deterioration). Heart rate monitoring during activity (keeping below 60–65% of maximum heart rate) helps prevent aerobic threshold breaches that trigger PEM.

Sleep: Addressing sleep architecture disruption is important. Fixed wake times, sleep hygiene interventions, and in some cases melatonin or low-dose tricyclics for sleep quality. Spending excessive time in bed is counterproductive.

Orthostatic management (where POTS is present): Increased sodium and fluid intake, compression garments (waist-high), elevating the head of the bed, and recumbent exercise (rowing, cycling, swimming) avoid triggering orthostatic stress while maintaining fitness.

Symptom management: Pain (low-dose naltrexone has emerging evidence in ME/CFS specifically), headaches, nausea, and other symptoms can be managed symptomatically while addressing the underlying condition.

Nutritional support: Mitochondrial-supporting nutrients (CoQ10, magnesium, B vitamins, D-ribose) are used by some patients and clinicians. Evidence is preliminary but rationale is sound given the mitochondrial dysfunction findings. Addressing any deficiencies (vitamin D, iron, B12) is important as they compound ME/CFS fatigue.

What to avoid: Pushing through fatigue, graded exercise programs that increase intensity progressively, and any approach that repeatedly triggers PEM.

Prognosis and Long-Term Outlook

ME/CFS has a variable course. Some people improve significantly over time, particularly those with mild-to-moderate severity and access to good specialist care. A smaller proportion develop severe or very severe ME/CFS with significant disability. The outcomes are better with earlier diagnosis and appropriate management, and significantly worse when PEM is repeatedly triggered through inappropriate activity.

Long COVID has prompted unprecedented research investment in ME/CFS mechanisms — which gives reason for cautious optimism about future therapeutic developments.

Sources

• NHS — ME/CFS

Frequently Asked Questions

What causes chronic fatigue syndrome?

The exact cause isn't fully established, but three mechanisms are consistently identified: immune system dysfunction (persistent inflammatory activation and cytokine elevation after infection), autonomic nervous system disruption (impaired heart rate and blood pressure regulation, POTS), and mitochondrial energy failure (impaired ATP production at a cellular level). Viral infections — particularly Epstein-Barr virus and COVID-19 — are the most common known triggers.

What is the difference between ME/CFS and regular fatigue?

The key difference is post-exertional malaise — the worsening of all symptoms after physical or cognitive activity, with delayed onset (12–48 hours later) and disproportionate severity. Ordinary fatigue improves with rest; ME/CFS fatigue does not, and exertion makes it significantly worse. The functional impairment is also characteristic: ME/CFS substantially reduces the ability to do activities that were previously normal.

How is ME/CFS diagnosed?

Diagnosis is clinical, based on NICE 2021 criteria: substantial functional impairment for 3+ months, post-exertional malaise, unrefreshing sleep, and either cognitive impairment or orthostatic intolerance. Other conditions that might explain the symptoms must be ruled out first. There is no confirmatory blood test.

Is graded exercise therapy recommended for ME/CFS?

No — the 2021 NICE guidelines removed graded exercise therapy from recommended treatments for ME/CFS, after evidence that it worsens outcomes in patients with post-exertional malaise. Pacing and energy management — staying within the energy envelope rather than progressively increasing activity — is now the recommended approach.

What management strategies are effective for ME/CFS?

Pacing (energy envelope management), orthostatic management for those with POTS, symptomatic treatment for pain and sleep, and addressing nutritional deficiencies. Behavioural and psychological support for living with a chronic illness (not aimed at "curing" the condition through belief change) is also appropriate. Early specialist referral improves outcomes.